Prospective Study to Evaluate High Flow Nasal Cannula With Monitored Anesthesia Care During EBUS Bronchoscopy

ConditionLung Cancer

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18+

SponsorThe Cooper Health System

About this trial

Our objective is to assess whether the use of high flow nasal cannula (Vapotherm, Exeter, NH) with monitored anesthesia care (MAC) during an endobronchial ultrasound (EBUS) bronchoscopy procedure will lead to less procedure interruptions, less hypoxic episodes, shorter duration of hypoxic episodes and shorter procedural durations when compared to regular MAC using a regular nasal canula.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

age>18 years

patient undergoing EBUS bronchoscopy with moderate conscious sedation.

Disqualifiers

subjects with previous nasal surgeries

subjects with oxygen saturation <90% on room air prior to procedure

subjects who are pregnant

subjects with known facial fractures or recent facial trauma

Trial design

Design model

Parallel

Treatments tested in this trial

Vapotherm
Device
Monitored anesthesia care with oxygen supplementation through a high-flow nasal cannula
Regular nasal canula
Device
Monitored anesthesia care with oxygen supplementation through a regular nasal cannula

Treatment groups

198 Participants

are divided into 2 treatment groups

Group A: High flow nasal cannula oxygenExperimental treatment 1 intervention

Group B: Regular nasal cannulaActive comparator 1 intervention

Trial outcomes

Primary outcomes

Number of interruption during EBUS procedure for hypoxia

We will count the number of interruptions during EBUS procedure for hypoxia

Time frame

1 day

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

The Cooper Health System

Lead sponsor

Source ClinicalTrials.gov

Apply now